Abstract: A healthcare payment management system comprising a payment consolidation server configured to receive billing information from a provider for an episode of care for a member, receive benefit information from a payer for the episode of care, consolidate the billing information and the benefit information into a payment reconciliation statement, and send the payment reconciliation statement to a member.

Abstract: Provided herein are nucleic acid tags that are linked to, or capable of linking to, a protein of interest. In particular, the nucleic acid tags are oligonucleotides comprising a reporter function and a protein tagging function. Also provided herein, are nucleic acid tag compositions, kits and methods of use thereof.

Abstract: The present invention concerns the use of oxygen antagonists and other active compounds for inducing stasis or pre-stasis in cells, tissues, and/or organs in vivo or in an organism overall, in addition to enhancing their survivability. It includes compositions, methods, articles of manufacture and apparatuses for enhancing survivability and for achieving stasis or pre-stasis in any of these biological materials, so as to preserve and/or protect them. In specific embodiments, there are also therapeutic methods and apparatuses for organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia, and cancer using the active compounds described.

Abstract: Provided herein are nucleic acid tags that are linked to, or capable of linking to, a protein of interest. In particular, the nucleic acid tags are oligonucleotides comprising a reporter function and a protein tagging function. Also provided herein, are nucleic acid tag compositions, kits and methods of use thereof.

Abstract: Provided herein are nucleic acid tags that are linked to, or capable of linking to, a protein of interest. In particular, the nucleic acid tags are oligonucleotides comprising a reporter function and a protein tagging function. Also provided herein, are nucleic acid tag compositions, kits and methods of use thereof.

Abstract: The present invention concerns the use of oxygen antagonists and other active compounds for inducing stasis or pre-stasis in cells, tissues, and/or organs in vivo or in an organism overall, in addition to enhancing their survivability. It includes compositions, methods, articles of manufacture and apparatuses for enhancing survivability and for achieving stasis or pre-stasis in any of these biological materials, so as to preserve and/or protect them. In specific embodiments, there are also therapeutic methods and apparatuses for organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia, and cancer using the active compounds described.

Abstract: A technique for classifying traffic at a network node includes programming multiple on-chip memory arrays with identical search entries, receiving multiple packets, and distributing classification searches related to the packets among the multiple on-chip memory arrays. In an embodiment, the on-chip memory arrays are content-addressable memory (CAM) arrays. In another embodiment, the distributing of classification searches related to the packets is performed in an alternating fashion with respect to a fixed order.

Abstract: A healthcare payment management system comprising a payment consolidation server configured to receive billing information from a provider for an episode of care for a member, receive benefit information from a payer for the episode of care, consolidate the billing information and the benefit information into a payment reconciliation statement, and send the payment reconciliation statement to a member.

Abstract: The present invention concerns the use of polychalcogenide compositions on cells, tissue, organs, and organisms to enhance their survivability. It includes compositions, compounds, methods, articles of manufacture and apparatuses for enhancing survivability and for protecting them from or treating them for injury or damage. In specific embodiments, there are also therapeutic methods and apparatuses for hypoxic/ischemic injury, organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia, and cancer using the polychalcogenide compositions described.

Abstract: The present invention concerns the use of oxygen antagonists and other active compounds for inducing stasis or pre-stasis in cells, tissues, and/or organs in vivo or in an organism overall, in addition to enhancing their survivability. It includes compositions, methods, articles of manufacture and apparatuses for enhancing survivability and for achieving stasis or pre-stasis in any of these biological materials, so as to preserve and/or protect them. In specific embodiments, there are also therapeutic methods and apparatuses for organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia, and cancer using the active compounds described.

Abstract: A packet-based traffic switching system with error detection and correction without taking the system offline. The system tests offline paths without interfering with other online paths. Also, the system tests online paths even while no data cell traffic is sent over the paths. The system responds to the addition or removal of paths or path components without interrupting cell traffic. The system detects and selectively flushes defective paths without impacting paths that are working properly. The system initializes new switching fabrics automatically without using software to set values. Thus, the system tests online paths and corrects errors without going offline.

Abstract: A traffic forwarding system that uses a multicast start-of-packet (SOP) pointer to enqueue a multicast packet in packet queues. The system receives cells, assigns pointers to the cells, and stores the received cells in memory. The system assigns multicast SOP pointers to multicast SOP cells. The system reassembles cells into packets and enqueues the packets in packet queues for forwarding. A multicast packet is enqueued in a plurality of packet queues. The memory in which the multicast packet is stored is released after the multicast packet is dequeued from each of the plurality of packet queues.

Abstract: Provided herein are nucleic acid tags that are linked to, or capable of linking to, a protein of interest. In particular, the nucleic acid tags are oligonucleotides comprising a reporter function and a protein tagging function. Also provided herein, are nucleic acid tag compositions, kits and methods of use thereof.

Abstract: A two stage rate shaping and scheduling system and method is implemented to control the flow of traffic to at least one output interface. The system and method involves initially queuing incoming packets into type-specific queues and applying individual rate shaping rules to each queue. A first stage arbitration is performed to determine how traffic is queued from the type-specific queues to interface-specific queues. Packets that win arbitration and pass the applied rate shaping rules are queued in interface-specific queues. Rate shaping rules are applied to the interface-specific queues. The interface-specific queues are further distinguished by priority and priority-specific and interface-specific rate shaping rules are applied to each queue. A second stage arbitration is performed to determine how different priority traffic that is targeting the same output interface is dequeued in response to interface-specific requests.

Abstract: The present invention concerns the use of polychalcogenide compositions on cells, tissue, organs, and organisms to enhance their survivability. It includes compositions, compounds, methods, articles of manufacture and apparatuses for enhancing survivability and for protecting them from or treating them for injury or damage. In specific embodiments, there are also therapeutic methods and apparatuses for hypoxic/ischemic injury, organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia, and cancer using the polychalcogenide compositions described.

Abstract: The present invention concerns the use of active compounds for inducing apnea and treating shock, in addition to enhancing the survivability of a subject. It includes compositions, methods, articles of manufacture and apparatuses for enhancing survivability and for achieving these effects.

Abstract: The present invention concerns the use of oxygen antagonists and other active compounds for inducing stasis or pre-stasis in cells, tissues, and/or organs in vivo or in an organism overall, in addition to enhancing their survivability. It includes compositions, methods, articles of manufacture and apparatuses for enhancing survivability and for achieving stasis or pre-stasis in any of these biological materials, so as to preserve and/or protect them. In specific embodiments, there are also therapeutic methods and apparatuses for organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia, and cancer using the active compounds described.

Abstract: The present invention concerns the use of oxygen antagonists and other active compounds for inducing stasis or pre-stasis in cells, tissues, and/or organs in vivo or in an organism overall, in addition to enhancing their survivability. It includes compositions, methods, articles of manufacture and apparatuses for enhancing survivability and for achieving stasis or pre-stasis in any of these biological materials, so as to preserve and/or protect them. In specific embodiments, there are also therapeutic methods and apparatuses for organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia, and cancer using the active compounds described.

Abstract: A system for efficiently reassembling packets from cells received on independent switching fabrics according to a serial high speed interface (HSI) protocol. The system includes redundancy in that fabrics may be removed by skipping the fabrics in striping and reassembly sequences. When fabrics are added, the fabrics are included in the striping and reassembly sequences. The system is efficient due in part to in-order transmission of cells serially across multiple fabrics. Full fabric bandwidth is thereby utilized without reordering overhead. Since packets are striped across all available fabrics, load is balanced across the fabrics.

Abstract: A technique for classifying traffic at a network node involves programming a content addressable memory (CAM) array with multiple class-specific entries, where each of the class-specific entries has an associated traffic class, obtaining a protocol-independent key field from an incoming packet, and searching the programmed CAM array with the protocol-independent key field to identify an associated traffic class of the incoming packet. In another embodiment, each of the class-specific entries has an associated traffic distribution policy, which may be applied to an incoming packet.